Inogen Inc (INGN)

Official site

HEALTHCARE • MEDICAL DEVICES • NASDAQ

$6.29

+0.17 (+2.69%)

Market Cap: $162.68M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

77%(30/39)

Avg Surprise

+45.74%

Streak

10 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.06

Range$-0.06 - $-0.06

1 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate DriftChange to current

90d ago$0.00n/a

60d ago$0.00n/a

30d ago$0.00n/a

7d ago$0.01-700.0%

Current$-0.06

Revenue Consensus

$92M

Range$92M - $92M

2 analysts

Period ending Dec 31, 2026

EPS Consensus$0.05

Range$0.05 - $0.05

1 analysts

Revenue Consensus

$87M

Range$85M - $88M

2 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.05	$0.05 - $0.05	-	-	1	-	-
Sep 30, 2026Sep 26EST	-	$-0.06	$-0.06 - $-0.06	-	-	1	0 1 30d	-
Jun 30, 2026Jun 26 Reported Aug 6, 2026Reported Aug 6	$-0.14	$-0.17	$-0.17 - $-0.17	+17.65%	Beat	1	No revisions (30d)	+6.7%
Mar 31, 2026Mar 26 Reported May 7, 2026Reported May 7	$-0.14	$-0.21	$-0.21 - $-0.21	+33.33%	Beat	1	No revisions (30d)	-27.3%
Dec 31, 2025Dec 25 Reported Feb 24, 2026Reported Feb 24	$-0.15	N/A	-	+56.19%	Beat	1	No revisions (30d)	+37.5%
Sep 30, 2025Sep 25 Reported Nov 5, 2025Reported Nov 5	$-0.20	$-0.22	$-0.22 - $-0.22	+9.09%	Beat	1	No revisions (30d)	-81.8%
Jun 30, 2025Jun 25 Reported Aug 7, 2025Reported Aug 7	$-0.15	$-0.22	$-0.22 - $-0.22	+31.82%	Beat	1	No revisions (30d)	-114.3%
Mar 31, 2025Mar 25 Reported May 7, 2025Reported May 7	$-0.11	N/A	-	+56.00%	Beat	1	No revisions (30d)	+75.6%
Dec 31, 2024Dec 24 Reported Feb 25, 2025Reported Feb 25	$-0.24	N/A	-	+51.02%	Beat	1	0 1 30d	+78.9%
Sep 30, 2024Sep 24 Reported Nov 7, 2024Reported Nov 7	$-0.11	N/A	-	+59.26%	Beat	4	No revisions (30d)	+69.4%
Jun 30, 2024Jun 24 Reported Aug 6, 2024Reported Aug 6	$-0.07	N/A	-	+82.05%	Beat	4	No revisions (30d)	+82.5%
Mar 31, 2024Mar 24 Reported May 7, 2024Reported May 7	$-0.45	$-0.58	$-0.67 - $-0.47	+22.41%	Beat	4	No revisions (30d)	+42.3%
Dec 31, 2023Dec 23 Reported Feb 27, 2024Reported Feb 27	$-1.14	$-0.62	$-0.71 - $-0.57	-83.87%	Miss	4	No revisions (30d)	-470.0%
Sep 30, 2023Sep 23 Reported Nov 7, 2023Reported Nov 7	$-0.36	$-0.23	$-0.39 - $-0.14	-56.52%	Miss	4	No revisions (30d)	+14.3%
Jun 30, 2023Jun 23 Reported Aug 7, 2023Reported Aug 7	$-0.40	$-0.60	$-0.69 - $-0.46	+33.33%	Beat	4	No revisions (30d)	-166.7%
Mar 31, 2023Mar 23 Reported May 4, 2023Reported May 4	$-0.78	$-0.75	$-1.01 - $-0.70	-4.00%	Miss	4	No revisions (30d)	-25.8%
Dec 31, 2022Dec 22 Reported Feb 23, 2023Reported Feb 23	$-0.20	N/A	-	+64.91%	Beat	5	No revisions (30d)	+80.2%
Sep 30, 2022Sep 22 Reported Nov 2, 2022Reported Nov 2	$-0.42	$-0.38	$-0.55 - $-0.30	-10.53%	Miss	5	No revisions (30d)	-179.2%
Jun 30, 2022Jun 22 Reported Aug 4, 2022Reported Aug 4	$-0.15	N/A	-	+54.55%	Beat	5	No revisions (30d)	-168.2%
Mar 31, 2022Mar 22 Reported May 5, 2022Reported May 5	$-0.62	$-0.51	$-0.64 - $-0.35	-21.57%	Miss	5	No revisions (30d)	-1966.7%
Dec 31, 2021Dec 21 Reported Feb 24, 2022Reported Feb 24	$-1.01	$-0.73	$-0.79 - $-0.69	-38.36%	Miss	5	2 0 30d	-339.1%
Sep 30, 2021Sep 21 Reported Nov 4, 2021Reported Nov 4	$0.53	$-0.29	$-0.50 - $-0.10	+282.76%	Beat	6	No revisions (30d)	+762.5%
Jun 30, 2021Jun 21 Reported Aug 4, 2021Reported Aug 4	$0.22	$-0.10	$-0.17 - $0.22	+320.00%	Beat	6	2 0 30d	+83.3%
Mar 31, 2021Mar 21 Reported May 4, 2021Reported May 4	$-0.03	N/A	-	+88.46%	Beat	6	1 0 30d	+57.1%
Dec 31, 2020Dec 20 Reported Feb 24, 2021Reported Feb 24	$-0.23	$-0.26	$-0.32 - $-0.17	+11.54%	Beat	6	No revisions (30d)	-283.3%
Sep 30, 2020Sep 20 Reported Nov 4, 2020Reported Nov 4	$-0.08	$-0.09	$-0.21 - $0.19	+11.11%	Beat	6	No revisions (30d)	-125.8%
Jun 30, 2020Jun 20 Reported Aug 4, 2020Reported Aug 4	$0.12	$-0.06	$-0.24 - $0.20	+300.00%	Beat	6	No revisions (30d)	-73.3%
Mar 31, 2020Mar 20 Reported May 5, 2020Reported May 5	$-0.07	$-0.11	$-0.12 - $-0.08	+36.36%	Beat	6	No revisions (30d)	-129.2%
Dec 31, 2019Dec 19 Reported Feb 25, 2020Reported Feb 25	$-0.06	$0.10	$0.08 - $0.15	-160.00%	Miss	6	No revisions (30d)	-113.6%
Sep 30, 2019Sep 19 Reported Nov 5, 2019Reported Nov 5	$0.31	$0.22	$0.21 - $0.28	+40.91%	Beat	7	No revisions (30d)	-57.5%
Jun 30, 2019Jun 19 Reported Aug 7, 2019Reported Aug 7	$0.45	$0.49	$0.41 - $0.63	-8.16%	Miss	7	No revisions (30d)	-30.8%
Mar 31, 2019Mar 19 Reported May 7, 2019Reported May 7	$0.24	$0.33	$0.17 - $0.40	-27.27%	Miss	7	1 0 30d	-50.0%
Dec 31, 2018Dec 18 Reported Feb 26, 2019Reported Feb 26	$0.44	$0.25	$0.20 - $0.35	+76.00%	Beat	7	No revisions (30d)	+41.9%
Sep 30, 2018Sep 18 Reported Nov 6, 2018Reported Nov 6	$0.73	$0.53	$0.53 - $0.53	+37.74%	Beat	0	No revisions (30d)	+121.2%
Jun 30, 2018Jun 18 Reported Aug 7, 2018Reported Aug 7	$0.65	$0.44	$0.42 - $0.49	+47.73%	Beat	7	1 0 30d	+71.1%
Mar 31, 2018Mar 18 Reported Apr 30, 2018Reported Apr 30	$0.48	$0.29	$0.17 - $0.36	+65.52%	Beat	6	No revisions (30d)	+77.8%
Dec 31, 2017Dec 17 Reported Feb 27, 2018Reported Feb 27	$0.31	$0.23	$0.18 - $0.29	+34.78%	Beat	6	No revisions (30d)	+24.0%
Sep 30, 2017Sep 17 Reported Nov 7, 2017Reported Nov 7	$0.33	$0.29	$0.24 - $0.33	+13.79%	Beat	6	No revisions (30d)	-
Jun 30, 2017Jun 17 Reported Aug 3, 2017Reported Aug 3	$0.38	$0.28	$0.24 - $0.32	+35.71%	Beat	6	No revisions (30d)	-
Mar 31, 2017Mar 17 Reported May 9, 2017Reported May 9	$0.27	$0.14	-	+92.86%	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Feb 28, 2017Reported Feb 28	$0.25	$0.11	-	+127.27%	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-9.99	EV/EBITDA	N/A
Price/FCF	-34.17x	FCF Yield	-2.93%
Profitability
Profit Margin	-6.94%	Operating Margin	-5.13%
ROE	-13.10%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	2.74x	Quick Ratio	2.34x
Trading Statistics
Beta	1.50	Avg Volume	394.79K
52-Week High	$9.13	52-Week Low	$5.04

Technical Indicators Dashboard

Moving Averages

SMA 10$6.08

SMA 20$5.70

SMA 50$5.61

SMA 200$6.22

EMA 10$6.06

EMA 20$5.85

EMA 50$5.78

EMA 200$6.25

MACD

Line: 0.21Signal: 0.13Hist: 0.08

ADX

ADX: 38.8+DI: 33.4-DI: 16.4

Aroon & PSAR

Aroon Up92.0

Aroon Down36.0

PSAR$5.80

Bollinger Bands

Upper Band$6.61

Lower Band$4.79

%B Position3198%(Upper)

Band Width0.83

RSI (14-Day)

Neutral

64.3

Momentum Oscillators

Stoch %K81.0

Stoch %D86.6

Williams %R-16.9

ROC (10d)5.3%

Momentum0.32

CCI (20d)99.0

MFI (14d)72.3

Volatility Measures

ATR (14d)$0.24(3.7%)

StdDev (20d)0.46

Hist Vol58.5%(High)

Volume Flow

VWAP$6.29

OBV-2.9K

AD Line-4.1M

CMF (20d)0.089

Volume Metrics

Avg Vol (20d)390.0K

Vol Ratio0.4x(Low)

VWMA (20d)$5.66

Pivot Points

R3$6.55

R2$6.44

R1$6.28

Pivot Point$6.17

S1$6.01

S2$5.90

S3$5.74

Advanced Oscillators

TSI25.33

Ultimate Osc60.2

KST120.16

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$95.08M	$85.11M	$81.72M	$92.39M	$92.28M	$82.28M	$80.08M	$88.83M	$88.77M	$78.03M	$75.90M	$83.97M
Cost of Revenue	$51.81M	$47.25M	$46.48M	$51.07M	$50.94M	$45.91M	$43.79M	$47.49M	$46.03M	$43.65M	$47.74M	$50.20M
Gross Profit	$43.27M	$37.86M	$35.24M	$41.32M	$41.34M	$36.37M	$36.29M	$41.34M	$42.74M	$34.37M	$28.16M	$33.76M

Operating Expenses	$48.37M	$47.20M	$44.54M	$48.43M	$47.47M	$44.03M	$47.67M	$49.14M	$49.80M	$50.65M	$57.14M	$80.48M
R&D	$5.87M	$5.10M	$5.32M	$4.84M	$5.21M	$4.03M	$5.90M	$3.52M	$5.62M	$6.58M	$6.71M	$4.49M
SG&A	$17.67M	$17.50M	$16.12M	$18.15M	$16.87M	$16.24M	$17.62M	$19.26M	$18.57M	$17.13M	$24.77M	$17.01M
Operating Income	$-5,096,000	$-9,336,000	$-9,306,000	$-7,116,000	$-6,129,000	$-7,656,000	$-11,386,000	$-7,792,000	$-7,064,000	$-16,274,000	$-28,982,000	$-46,721,000

Interest Income	$861,000	$880,000	$1.16M	$1.07M	$1.12M	$1.03M	$1.41M	$1.04M	$1.33M	$1.40M	$1.60M	$1.80M
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$-4,004,000	$-8,498,000	$-7,363,000	$-5,440,000	$-4,305,000	$-6,271,000	$-10,087,000	$-6,064,000	$-5,597,000	$-14,728,000	$-27,088,000	$-45,318,000
Income Tax Expense	$-154,000	$-174,000	$-236,000	$-146,000	$-153,000	$-97,000	$-330,000	$-101,000	$-7,000	$-150,000	$-533,000	$401,000

Net Income	$-3,850,000	$-8,324,000	$-7,127,000	$-5,294,000	$-4,152,000	$-6,174,000	$-9,757,000	$-5,963,000	$-5,590,000	$-14,578,000	$-26,555,000	$-45,719,000

EBITDA	$-168,000	$-4,474,000	$-3,491,000	$-1,291,000	$-212,000	$-2,111,000	$-6,420,000	$-1,791,000	$-1,585,000	$-10,866,000	$-23,546,000	$-42,505,000
EBIT	$-4,865,000	$-9,378,000	$-8,526,000	$-6,510,000	$-5,428,000	$-7,300,000	$-11,500,000	$-7,105,000	$-6,930,000	$-16,131,000	$-28,690,000	$-47,119,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about INGN

Government Contracts

Gov Obligations (TTM)

$23494

Gov Obligations / Revenue

0.0%

Obligations YoY

N/A

Active Awards

New Awards (TTM)

Avg Remaining Term

N/A

Top agency: Department of Justice at 100.0% of trailing twelve month obligations across 1 agencies

Recent Awards

Award ID	Agency	Obligated	Start	End	Description
15B10925P00000187	Department of JusticeFederal Prison System / Bureau of Prisons	$23494	Sep 3, 2025	Sep 30, 2025	17 PORTABLE OXYGEN CONCENTRATORS

Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

News

Inogen to report Q3FY26 results on November 5, 2026

Inogen, Inc. announced it will release its third-quarter 2026 financial results after market close on November 5, 2026...

scanx.trade•Oct 15, 2026 1:41 PM ET10/15/26•Neutral

What Inogen Investors Missed Before The Fall

Inogen's recent Q2 2026 financial report showed revenue of US$95.084 million and a reduced net loss, yet investors are down 24.3% over the past year. The article highlights the importance of net margin improvement over...

Simply Wall Street•Oct 14, 2026 9:12 AM ET10/14/26•Neutral

Full Transcript: Inogen Q2 2026 Earnings Call

Inogen reported a 3% year-over-year revenue increase to $95.1 million in Q2 2026, driven by strong international growth and new products...

Benzinga•Oct 13, 2026 4:42 AM ET10/13/26•Neutral

Inogen stock sharpens its focus with a USD 25 million sale

Inogen (INGN) is strategically selling its U.S. oxygen rental assets to Rotech for up to $25 million to refocus its business on product sales and distribution. This move, accompanied by a long-term supply agreement...

AD HOC NEWS•Oct 7, 2026 11:26 PM ET10/7/26•Somewhat-Bullish

Inogen stock faces a strategic reset after rental sale

Inogen has agreed to sell its U.S. oxygen rental business to Rotech Healthcare for up to $25 million, a strategic divestiture aimed at improving business mix and profitability. The rental unit generated $24.3 million...

AD HOC NEWS•Oct 4, 2026 4:11 AM ET10/4/26•Somewhat-Bullish

INGN Valuation and Fair Value

P/E: -10.0x
P/FCF: -34.2x
PEG: 3.5x
P/B: 1.0x

See GNG's fair value

INGN Profitability: Margins, ROIC and FCF

Gross margin: 44.5%
Operating margin: -5.1%
Net margin: -6.9%
ROE: -13.1%
FCF margin: -1.4%
FCF yield: -2.9%

INGN Competitors

Company	Ticker
PepGen Ltd	PEPG
EDAP TMS SA	EDAP
Innate Pharma	IPHA
Journey Medical Corp	DERM
Coherus BioSciences Inc	CHRS
Quipt Home Medical Corp	QIPT
Precision BioSciences Inc	DTIL
Compass Therapeutics Inc.	CMPX

Sector: Healthcare

INGN Bull Case vs Bear Case

Bull case

INGN beat EPS estimates in 100.0% of its last 8 reported quarters.

Bear case

INGN has a -6.9% net profit margin.

INGN Earnings: Beat Rate and Next Report

Beat rate: 8 of 8 quarters (100.0%)
Average surprise: 39.3%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.06
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 0 up, 1 down

Frequently Asked Questions About INGN

Does INGN pay dividends?

Inogen Inc (INGN) does not currently pay a regular dividend.

What is INGN's market cap?

Inogen Inc (INGN) has a market capitalization of $162.68M with a current stock price of $6.29.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In